DOYLESTOWN, PA. - October 10, 2008 - The Quigley Corporation (Nasdaq: QGLY)
maker of the popular Cold-EEZE® zinc lozenges,
http://www.cold-eeze.com,
is introducing new Kids-EEZE® Chest Relief,
http://www.kids-eeze.com a
single-ingredient, allopathic expectorant with guaifenesin to help children,
ages six and up, suffering from uncomfortable chest congestion. Kids-EEZE®
Chest Relief provides an alternative to the many multi-symptom children's cold
products that could potentially lead to overmedication.
Kids-EEZE® Chest Relief is a unique, patented soft chew, available in
great-tasting strawberry and grape flavors, that offers relief of chest
congestion in a convenient dosage form for children six years of age and older.
"In recent years, the cough and cold remedy category has seen a growth in
multi-symptom cold remedies, which has led to concerns about parents
overmedicating their kids and treating symptoms their children weren't actually
suffering from," says Albert Piechotta, executive director of
communications and investor relations at the Quigley Corporation.
"Kids-EEZE® Chest Relief, however, bucks the trend and helps simplify
it for parents, since it has only one purpose and one ingredient —
treating chest congestion with guaifenesin."
Guaifenesin is an expectorant
that helps thin and loosen phlegm, or mucus, so that children can easily expel
it from their lungs, relieving painful chest congestion and making coughs more
productive.
"Chest congestion is a typical symptom of the common cold and one that is
uncomfortable for children," says Paul Horowitz, M.D., F.A.A.P., of
Discovery Pediatrics in Valencia, California. "Making a cough more
productive can really make the child feel better and reduce the chances of that
chest congestion turning into something more serious."
Each box of Kids-EEZE® Chest Relief contains 12, individually-wrapped,
kid-friendly soft chews with 100 mg of guaifenesin. The convenience of a soft
chew also ensures that children are getting the full dosage of guaifenesin,
without possible liquid spills, making it easier for parents to administer.
Kids-EEZE® Chest Relief is available nationwide at major retailers,
including supermarkets, mass market retailers and chain and independent drug
stores, as well as via online retailers, for a suggested price of $7.99.
For more information and cold and flu tips, visit
http://www.kids-eeze.com.
About The Quigley Corporation
The Quigley Corporation (NASDAQ: QGLY, http://www.Quigleyco.com) is a
diversified natural health medical science company. Its Cold Remedy segment is
a leading marketer and manufacturer of the COLD-EEZE® family of lozenges,
and sugar free tablets clinically proven to cut the common cold nearly in half.
COLD-EEZE customers include leading national wholesalers and distributors, as
well as independent and chain food, drug and mass merchandise stores and
pharmacies. The Quigley Corporation has wholly owned subsidiaries; Quigley
Manufacturing Inc. consists of two FDA approved facilities to manufacture COLD-
EEZE® lozenges as well as fulfill other contract manufacturing
opportunities and Quigley Pharma Inc. (http://www.QuigleyPharma.com) conducts
research in order to develop and commercialize a pipeline of patented botanical
and naturally derived potential prescription drugs.
Forward-Looking Statements
Certain statements in this press release are "forward-looking
statements" within the meaning of the Private Securities Litigation Reform
Act of 1995 and involve known and unknown risk, uncertainties and other factors
that may cause the Company's actual performance or achievements to be
materially different from the results, performance or achievements expressed or
implied by the forward-looking statement. Factors that impact such
forward-looking statements include, among others, changes in worldwide general
economic conditions, changes in interest rates, government regulations, and
worldwide competition.
